heart disease

Cannabinoids, The Heart of the Matter

GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the publication of a review article co-authored by GB Sciences and key collaborators in the Journal of the American Heart Association, which explains the potential medical benefits of using cannabinoid-based therapies for the treatment of heart diseases. GB Sciences’ own Chief Science Officer, Dr.¬†Andrea Small-Howard, joins